Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2006 Sep 21;12(35):5711-6.
doi: 10.3748/wjg.v12.i35.5711.

Chronic Epstein-Barr virus-related hepatitis in immunocompetent patients

Affiliations

Chronic Epstein-Barr virus-related hepatitis in immunocompetent patients

Mihaela Petrova et al. World J Gastroenterol. .

Abstract

Aim: To investigate reactivated Epstein-Barr virus (EBV) infection as a cause for chronic hepatitis.

Methods: Patients with occasionally established elevated serum aminotransferases were studied. HIV, HBV and HCV-infections were excluded as well as any other immunosuppressive factors, metabolic or toxic disorders. EBV viral capsid antigen (VCA) IgG and IgM, EA-R and EA-D IgG and Epstein-Barr nuclear antigen (EBNA) were measured using IFA kits. Immunophenotyping of whole blood was performed by multicolor flow cytometry. CD8(+) T cell responses to EBV and PHA were determined according to the intracellular expression of IFN-gamma.

Results: The mean alanine aminotransferase (ALT) and gamma glutamyl transpeptidase (GGTP) values exceeded twice the upper normal limit, AST/ALT ratio < 1. Serology tests showed reactivated EBV infection in all patients. Absolute number and percentages of T, B and NK cells were within the reference ranges. Fine subset analysis, in comparison to EBV(+) healthy carriers, revealed a significant decrease of naive T cells (P < 0.001), accompanied by increased percentage of CD45RA(-) (P < 0.0001), and terminally differentiated CD28(-)CD27(-)CD8(+) T cells (P < 0.01). Moderately elevated numbers of CD38 molecules on CD8(+) T cells (P < 0.05) proposed a low viral burden. A significantly increased percentage of CD8(+) T cells expressing IFN-gamma in response to EBV and PHA stimulation was registered in patients, as compared to controls (P < 0.05). Liver biopsy specimens from 5 patients revealed nonspecific features of low-grade hepatitis.

Conclusion: Chronic hepatitis might be a manifestation of chronic EBV infection in the lack of detectable immune deficiency; the expansion of CD28(-)CD27(-) and increase of functional EBV-specific CD8(+) T cells being the only surrogate markers of viral activity.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Significant differences detected between patients and control group by immunophenotyping. Patients were characterized by a decreased absolute number of naive CCCR7+CD45RA+CD4+ (A) and CD8+ (C) T cells, increased absolute number of memory CD45RA-CD4+ (B) and CD8+ (D)T cells, increased absolute number of effector CD28-CD27-CD8+ T cells (E), as well as by increased percentage of IFNγ+CD69+CD8+ T cells after stimulation with EBV peptide GLCTMVL (F) and with PHA (G). Box-and-whiskers indicate the 25-75 percentile and min-max values for each group. Mean values are designated on all plots by a horizontal line. Man-Witney. P values are indicated for each comparison.
Figure 2
Figure 2
Liver biopsy, showing lymphocyte infiltrate within the lobule and some hepatocyte injury, with mild steatosis displayed in some cells.

Similar articles

Cited by

References

    1. Rickinson AB, Kieff E. Epsterin-Barr virus. In: Knipe DM, Howley PM, editors. Field's Virology, 4th ed, Vol.2. Philadelphia: Lippincott Williams & Wilkins; 2001. pp. 2575–2627.
    1. Cohen JI. Epstein-Barr virus infection. N Engl J Med. 2000;343:481–492. - PubMed
    1. Kimura H, Hoshino Y, Kanegane H, Tsuge I, Okamura T, Kawa K, Morishima T. Clinical and virologic characteristics of chronic active Epstein-Barr virus infection. Blood. 2001;98:280–286. - PubMed
    1. Kimura H, Morishima T, Kanegane H, Ohga S, Hoshino Y, Maeda A, Imai S, Okano M, Morio T, Yokota S, et al. Prognostic factors for chronic active Epstein-Barr virus infection. J Infect Dis. 2003;187:527–533. - PubMed
    1. Straus SE. The chronic mononucleosis syndrome. J Infect Dis. 1988;157:405–412. - PubMed

MeSH terms

Substances